Dr. David Riley was born July 30th 1952, in Dallas, Texas.
He practices homeopathy half time since 1989, exclusively classical, occasionally homotoxicology. As for other therapies Dr. Riley uses therapeutic yoga and herbal medicine.
Dr. Riley has taught since 1989. His teaches in the US and Europe. He is affiliated with the Hahnemann College of Homeopathy and with Alternative Therapies in Health and Medicine.
Dr. Riley is the co-founder of the Integrative Medicine Institute and Southwest Health Options IPA. He is the medical editor of Alternative Therapies in Health and Medicine, and is in private medical practice in Santa Fe, New Mexico. Dr. Riley attended Georgetown University Medical School and graduated from the University of Utah Medical School in 1983.
He is currently a Diplomate of the American Board of Internal Medicine. In 1987 he became a certified yoga instructor and in 1993 completed a three-year training program in homeopathy at the Hahnemann College of Homeopathy in Albany, California. His medical practice focuses on integrating conventional and alternative therapies into patient care.
Southwest Health Options is an independent practice association (IPA) managing the delivery of complementary and alternative medicine (CAM) for insured patients in Santa Fe, New Mexico. As the medical director of Southwest Health Options, Dr. Riley directly oversees peer review and utilization management, and helps develop credentialing standards.
He is also the co-founder and director of the Integrative Medicine Institute, a research institute evaluating the process of integrating complementary and alternative therapies into the practice of medicine. In 1997 he began a CME approved training program for physicians interested in incorporating complementary medicine into their practices.
Dr. Riley has been the principle investigator on over 60 homeopathic drug provings in homeopathy. He was the principle investigator on the International Integrative Primary Care Outcome Study (IIPCOS-1). This multi-center outcomes study evaluated patient care outcomes when homeopathy was integrated in a primary care setting (publication of these results are pending).
He is also a board member of the Homeopathic Pharmacopoeia of the United States (HPCUS), a technical advisory board to the FDA for regulatory issues concerning homeopathy. Dr. Riley is Clinical Associate Professor at the University of New Mexico Medical School. Dr. Riley lectures and consults internationally on a wide range of health care issues.
- Email: email@example.com